Clinical trials: sponsored by University of Manitoba
Healthy Aging
Piloting a Healthy Aging Cohort in Manitoba
The purpose of this study is to set up and pilot baseline and year 1 data collection for a prospective cohort designed to explore the relationships between medical fitness facility usage, lifestyle behaviours and health outcomes…
- Trial name
- PACMan (NCT06100224)
- Where
- Canada
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- University of Manitoba
Schizophrenia, Healthy (Controls)
Exploring the Genetics of Schizophrenia in Manitoba
Schizophrenia is a serious mental illness that affects about 1 in 100 Canadians, shortens life expectancy, and places a large burden on individuals, families, and the healthcare system.
- Trial name
- GENES-MB (NCT07656870)
- Where
- Canada
- Volunteers
- 1,500 people, healthy volunteers welcome
- Sponsor
- University of Manitoba
ICU Acquired Weakness, Sepsis
ICU Combined Assessment of Cardio-Respiratory Exercise
This study aims to investigate how sepsis and critical illness can impair the cardiovascular system and microcirculation in intensive care unit (ICU) patients, which can lead to long-lasting muscle weakness/dysfunction or…
- Conditions
- ICU Acquired Weakness, Sepsis, Shock, Critical Illness
- Trial name
- ICU-CARE (NCT06193980)
- Where
- 2 sites in Canada
- Volunteers
- 50 people
- Sponsor
- University of Manitoba
Drug Resistant Epilepsy
CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children
Epilepsy is a neurological disorder affecting more than 50 million people globally, including more than 260,000 Canadians. Cannabidiol (CBD) reduces seizure frequency and improves quality of life for adults and children with Drug…
- Trial name
- CAN-DRE (NCT07023744)
- Testing
- CBD Isolate, CBD CHE
- Volunteers
- 90 people
- Sponsor
- University of Manitoba
Childhood Cancer, Cancer
CANnabinoids in Pediatric ONCology
CANnabinoids in Pediatric ONCology is a randomized, double blind, adaptive clinical trial looking at the tolerability of cannabinoids in children with cancer across 3 Canadian children's hospitals.
- Trial name
- CAN-PONC (NCT05754840)
- Testing
- MPL-001, MPL-005, MPL-009
- Where
- 3 sites in Canada
- Volunteers
- 60 people
- Sponsor
- University of Manitoba
Interstitial Lung Disease (ILD)
VR-Assisted Exercise for Symptom Management and Rehabilitation in Interstitial Lung Disease
This project aims to create and improve a VR-based breathing exercise program for patients with interstitial lung diseases (ILDs).
- Trial name
- NCT07628725
- Testing
- Flyer, VR-based
- Volunteers
- 32 people
- Sponsor
- University of Manitoba
Type 1 Diabetes, Physical Activity
Type 1 Diabetes, Exercise and Mentoring Trial
The proposed study aims to improve the psychosocial health of adolescents living with type 1 diabetes (T1D). The study will generate knowledge and support knowledge mobilization about the effectiveness of a novel model of care…
- Trial name
- TEAM (NCT06296992)
- Testing
- 12-week TEAM peer mentor program
- Where
- 2 sites in Canada
- Volunteers
- 60 people
- Sponsor
- University of Manitoba
Depression, Anxiety, Anger
Advancing Family Wellbeing Through a Massive Open Online Intervention: The LightBEAM Program
Early childhood is a critical period for developmental outcomes, and the parent-child relationship plays a vital role in shaping cognitive and social development.
- Conditions
- Depression, Anxiety, Anger, Parenting, Stress Psychological
- Trial name
- NCT07026838
- Testing
- The Light Building Emotional Awareness and Mental Health (BEAM) Program
- Where
- Canada
- Volunteers
- 202 people
- Sponsor
- University of Manitoba
Allergy to Peanut
Predictors of Persistent Peanut Allergy at Age 5 Years
The purpose of this study is to determine if avoidance of peanut by children with positive allergy testing to peanut in the first 5 years of life increases the likelihood of developing a persistent peanut allergy by age 5 years.
- Trial name
- NCT02497261
- Volunteers
- 200 people
- Sponsor
- University of Manitoba
End-stage Kidney Disease, Hemodialysis
Exercise and Cardiac Stunning During HD
The purpose of this study is to determine the effect of a 12-week cycling during hemodialysis program on hemodialysis-induced myocardial stunning in adult individuals receiving hemodialysis.
- Trial name
- NCT04877041
- Testing
- Intradialytic Cycling
- Where
- 6 sites in Australia, Canada
- Volunteers
- 111 people
- Sponsor
- University of Manitoba
Prediabetes, Type 2 Diabetes
Effects of Dried Whole Fruits on Metabolism in Diabetes
Diabetes becomes epidemic in worldwide countries. Diabetes Canada indicated that 30% of adults in Manitoba are diabetes or prediabetes. Nine out of ten diabetic patients are type 2 diabetes (T2D).
- Trial name
- NCT07354386
- Testing
- Freeze dried whole Saskatoon berry, Freeze dried apple slice bulk
- Where
- Canada
- Volunteers
- 92 people
- Sponsor
- University of Manitoba
Burn Scar
The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars
The purpose of this study is to determine the effects (good or bad) of pulsed dye laser treatment in burn scar height, texture, redness and pliability in acute burn injury.
- Trial name
- NCT01488240
- Testing
- pulsed dye laser
- Where
- Canada
- Volunteers
- 6 people
- Sponsor
- University of Manitoba
Burns
A Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries
Burn injuries can result in long term physical and mental sequelae, not only from the scarring but also the painful dressings. The standard of care today remains use of antibiotic topical dressings while awaiting demarcation of…
- Trial name
- NCT04893863
- Testing
- Standard dressing, PluroGel
- Where
- Canada
- Volunteers
- 20 people
- Sponsor
- University of Manitoba
Blood Loss, Surgical
Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury
The standard of care for treatment of burn injury is to inject a solution of epinephrine under the skin of the injured site in order to reduce blood loss during skin grafting.
- Trial name
- NCT01731444
- Testing
- Phenylephrine
- Where
- Canada
- Volunteers
- 24 people
- Sponsor
- University of Manitoba
Burn Scar
The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars
While the literature tends to support the use of laser therapy in the management of burn scars, there is a definite lack of appropriately powered, randomized controlled trials.
- Trial name
- NCT01619917
- Testing
- Fractional Vascular Laser
- Where
- Canada
- Volunteers
- 6 people
- Sponsor
- University of Manitoba
Burns
A Between Patient Study of Plurogel® Compared to Standard Topical Dressing in Burn Injuries
Burn injuries can result in long term physical and mental sequelae, not only from the scarring but also the painful dressings. The standard of care today remains use of antibiotic topical dressings while awaiting demarcation of…
- Trial name
- NCT05000983
- Testing
- PluroGel, Standard dressing
- Where
- Canada
- Volunteers
- 25 people
- Sponsor
- University of Manitoba
Burns, Pain, Acute
A Pilot Trial of Disposable Nitrous Oxide Canisters in Providing Pain Control During Burn Dressing Changes
Improvements in burn care have resulted in increased survival. Despite these improved outcomes one of the leading challenges of burn care remains providing adequate analgesia during routine wound care and dressing changes.
- Trial name
- NCT03695887
- Testing
- Nitrous Oxide Inhalant Product
- Where
- Canada
- Volunteers
- 30 people
- Sponsor
- University of Manitoba
Esophageal Cancer
Organ-Preserving Endoscopic Resection & Adjuvant RADIO-immuno-chemotherapy for Esophageal Cancer
The goal of this study is to assess the safety of delivering concurrent adjuvant chemoradiation or immuno-radiation therapy after EMR/ESD in pT1b/T2N0 esophageal cancer patients. The main objectives of the study are: 1.
- Trial name
- OPERARADIO (NCT05667298)
- Testing
- Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B), Adjuvant chemoradiotherapy
- Where
- Canada
- Volunteers
- 11 people
- Sponsor
- University of Manitoba
Microbial Colonization, Preterm Birth
Matching Donor Human Milk On Maternal Secretor Status (MMOMSS) Study
This study will evaluate the impact of matching donor human milk to the maternal secretor status of very preterm infants (<34 weeks gestation) on the gut microbiome.
- Trial name
- MMOMSS (NCT04130165)
- Testing
- Matched donor human milk
- Where
- Canada
- Volunteers
- 13 people
- Sponsor
- University of Manitoba
Infant Growth, Maternal Health
International Milk Composition (IMiC) Consortium
The IMiC Consortium will analyze milk from 1000 mother-infant dyads across 4 diverse settings (Tanzania, Pakistan, Burkina Faso and Canada).
- Conditions
- Infant Growth, Maternal Health, Infant Nutrition
- Trial name
- IMiC (NCT05119166)
- Testing
- Vitamin B3, Azithromycin, Fortified food supplement
- Where
- Canada
- Volunteers
- 1,000 people
- Sponsor
- University of Manitoba